MedTrace Logo

Assessment of the Effect of Omeprazole on Vicagrel in Healthy Subjects

NCT05651074 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-01-31

No results posted yet for this study

Summary

The primary objective of the study is to evaluate the effects of omeprazole on the PK and PD of a single dose of vicagrel in healthy subjects.

Conditions

  • Healthy Subjects

Interventions

DRUG

Vicagrel and omeprazole

18 mg vicagrel capsules and 40 mg omeprazole magnesium enteric-coated tablets

Sponsors & Collaborators

  • Jiangsu vcare pharmaceutical technology co., LTD

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-14
Primary Completion
2023-02-28
Completion
2023-04-30
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05651074 on ClinicalTrials.gov